119 related articles for article (PubMed ID: 9602327)
1. CD44 variant expression in inflammatory colonic mucosa is not disease specific but associated with increased crypt cell proliferation.
Fromont Hankard G; Cezard JP; Aigrain Y; Navarro J; Peuchmaur M
Histopathology; 1998 Apr; 32(4):317-21. PubMed ID: 9602327
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of CD44v6 and CD44v3 in ulcerative colitis but not colonic Crohn's disease.
Rosenberg WM; Prince C; Kaklamanis L; Fox SB; Jackson DG; Simmons DL; Chapman RW; Trowell JM; Jewell DP; Bell JI
Lancet; 1995 May; 345(8959):1205-9. PubMed ID: 7537840
[TBL] [Abstract][Full Text] [Related]
3. CD44v6 expression in inflammatory bowel disease is associated with activity detected by endoscopy and pathological features.
Camacho FI; Muñoz C; Sánchez-Verde L; Sáez AI; Alcántara M; Rodríguez R
Histopathology; 1999 Aug; 35(2):144-9. PubMed ID: 10460659
[TBL] [Abstract][Full Text] [Related]
4. CD44 isoform expression on colonic epithelium mediates lamina propria lymphocyte adhesion and is controlled by Th1 and Th2 cytokines.
Macdonald DC; Leir SH; Brooks C; Sanders E; Lackie P; Rosenberg W
Eur J Gastroenterol Hepatol; 2003 Oct; 15(10):1101-10. PubMed ID: 14501619
[TBL] [Abstract][Full Text] [Related]
5. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
Kruidenier L; Kuiper I; Lamers CB; Verspaget HW
J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
[TBL] [Abstract][Full Text] [Related]
6. Alterations in the immunohistochemical expression of Das-1 and CG-3 in colonic mucosal biopsy specimens helps distinguish ulcerative colitis from Crohn disease and from other forms of colitis.
Yantiss RK; Das KM; Farraye FA; Odze RD
Am J Surg Pathol; 2008 Jun; 32(6):844-50. PubMed ID: 18408596
[TBL] [Abstract][Full Text] [Related]
7. [Annexin A2 expression in intestinal mucosa of patients with inflammatory bowel disease and its clinical implications].
Zhang Z; Zhao X; Lv C; Li C; Zhi F
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Nov; 32(11):1548-52. PubMed ID: 23174572
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis in the intestinal mucosa of patients with inflammatory bowel disease: evidence of altered expression of FasL and perforin cytotoxic pathways.
Souza HS; Tortori CJ; Castelo-Branco MT; Carvalho AT; Margallo VS; Delgado CF; Dines I; Elia CC
Int J Colorectal Dis; 2005 May; 20(3):277-86. PubMed ID: 15503066
[TBL] [Abstract][Full Text] [Related]
9. Alterations in mucosal content of colonic glycoconjugates in inflammatory bowel disease defined by monoclonal antibodies.
Podolsky DK; Fournier DA
Gastroenterology; 1988 Aug; 95(2):379-87. PubMed ID: 3292335
[TBL] [Abstract][Full Text] [Related]
10. Toll-like receptor expression in crypt epithelial cells, putative stem cells and intestinal myofibroblasts isolated from controls and patients with inflammatory bowel disease.
Brown M; Hughes KR; Moossavi S; Robins A; Mahida YR
Clin Exp Immunol; 2014 Oct; 178(1):28-39. PubMed ID: 24828022
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical study of intestinal eosinophils in inflammatory bowel disease.
Carvalho AT; Elia CC; de Souza HS; Elias PR; Pontes EL; Lukashok HP; de Freitas FC; Lapa e Silva JR
J Clin Gastroenterol; 2003 Feb; 36(2):120-5. PubMed ID: 12544193
[TBL] [Abstract][Full Text] [Related]
12. Innate immunity and colonic inflammation: enhanced expression of epithelial alpha-defensins.
Wehkamp J; Schwind B; Herrlinger KR; Baxmann S; Schmidt K; Duchrow M; Wohlschläger C; Feller AC; Stange EF; Fellermann K
Dig Dis Sci; 2002 Jun; 47(6):1349-55. PubMed ID: 12064812
[TBL] [Abstract][Full Text] [Related]
13. Expression and Clinical Significance of Elafin in Inflammatory Bowel Disease.
Zhang W; Teng G; Wu T; Tian Y; Wang H
Inflamm Bowel Dis; 2017 Dec; 23(12):2134-2141. PubMed ID: 29084078
[TBL] [Abstract][Full Text] [Related]
14. Analysis of direct tissue isoelectric focused protein profiles of resected intestinal mucosa and endoscopic biopsies from patients with inflammatory bowel disease.
Szewczuk MR; Depew WT
Clin Invest Med; 1992 Feb; 15(1):49-59. PubMed ID: 1374000
[TBL] [Abstract][Full Text] [Related]
15. Correlation of Biomarker Expression in Colonic Mucosa with Disease Phenotype in Crohn's Disease and Ulcerative Colitis.
Bruno ME; Rogier EW; Arsenescu RI; Flomenhoft DR; Kurkjian CJ; Ellis GI; Kaetzel CS
Dig Dis Sci; 2015 Oct; 60(10):2976-84. PubMed ID: 25956706
[TBL] [Abstract][Full Text] [Related]
16. Mucosal expression of interleukin-6 and interleukin-8 messenger RNA in ulcerative colitis and in Crohn's disease.
Arai F; Takahashi T; Furukawa K; Matsushima K; Asakura H
Dig Dis Sci; 1998 Sep; 43(9):2071-9. PubMed ID: 9753275
[TBL] [Abstract][Full Text] [Related]
17. Comparing the type and severity of inflammatory bowel disease in relation to IgG4 immunohistochemical staining.
Şimşek HD; Basyigit S; Aktas B; Vargol E; Şimşek GG; Küçükazman M; Nazlıgül Y
Acta Gastroenterol Belg; 2016; 79(2):216-21. PubMed ID: 27382941
[TBL] [Abstract][Full Text] [Related]
18. ATF4 Deficiency Promotes Intestinal Inflammation in Mice by Reducing Uptake of Glutamine and Expression of Antimicrobial Peptides.
Hu X; Deng J; Yu T; Chen S; Ge Y; Zhou Z; Guo Y; Ying H; Zhai Q; Chen Y; Yuan F; Niu Y; Shu W; Chen H; Ma C; Liu Z; Guo F
Gastroenterology; 2019 Mar; 156(4):1098-1111. PubMed ID: 30452920
[TBL] [Abstract][Full Text] [Related]
19. Keratinocyte growth factor in inflammatory bowel disease. Increased mRNA transcripts in ulcerative colitis compared with Crohn's disease in biopsies and isolated mucosal myofibroblasts.
Bajaj-Elliott M; Breese E; Poulsom R; Fairclough PD; MacDonald TT
Am J Pathol; 1997 Nov; 151(5):1469-76. PubMed ID: 9358773
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia inducible factor 1alpha and 2alpha overexpression in inflammatory bowel disease.
Giatromanolaki A; Sivridis E; Maltezos E; Papazoglou D; Simopoulos C; Gatter KC; Harris AL; Koukourakis MI
J Clin Pathol; 2003 Mar; 56(3):209-13. PubMed ID: 12610101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
